GSK plc.

In News

Is GSK plc (Common Stock) (GS70) stock undervalued after correction - Weekly Market Outlook & Accurate Entry/Exit Alerts - newser.com

newser.com - Nov 15, 2025

Deutsche Bank Maintains a Hold Rating on GSK plc (GSK) - Yahoo Finance

Yahoo Finance - Nov 12, 2025

GSK touts study showing acceptability edge for its long-acting PrEP drug amid Gilead showdown - Fierce Pharma

Fierce Pharma - Oct 15, 2025

GSK presents data from its advancing liver pipeline at AASLD 2025 - GSK

GSK - Nov 07, 2025

US FDA approves GSK's blood cancer treatment - Reuters

Reuters - Oct 24, 2025

Key facts: GSK plc buys 8.6M shares; announces director shareholding update - TradingView

TradingView - Nov 14, 2025

GSK pens $745M deal for phase 1 drug that hits sweet spots of COPD, oligonucleotides - Fierce Biotech

Fierce Biotech - Oct 28, 2025

GSK Executives Acquire Shares Under Reward Plan - TipRanks

TipRanks - Nov 13, 2025

GSK buys prostate cancer drug rights for £268m - The Times

The Times - Oct 27, 2025

Kahn Brothers' Strategic Moves: GSK PLC Sees a -3.08% Impact - Yahoo Finance

Yahoo Finance - Nov 12, 2025

Why GSK plc (Common Stock) (GS70) stock could be next leader - Earnings Risk Summary & High Accuracy Trade Signal Alerts - newser.com

newser.com - Nov 15, 2025

Global Fund welcomes renewed commitment from GSK and ViiV Healthcare to expand community-led health solutions with £6 million joint pledge ahead of 8th Replenishment - GSK

GSK - Oct 20, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment